EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells.

Biotechnology

Life Sciences

Medical Devices

Therapeutics

EdiTy Therapeutics

EdiTy Therapeutics' headquarters in Ness Ziona, Israel

Michal Golan-Mashiach

Sharon Avkin Nachum

Nurit Naor

Ofer Levy

Rick ’Kendall

Sandra Glucksmann

Eyal Kolka

The Research and Scientific Development team at EdiTy Therapeutics is responsible for advancing the company's gene-editing technology through innovative research and rigorous experimentation. This team, composed of diverse scientific expertise, collaborates to design experiments, analyze data, and translate discoveries into viable therapeutic solutions for target cells, ensuring the effective progression of projects from conception to clinical application.

Research and Scientific Development

The Leadership Team at EdiTy Therapeutics drives the strategic vision and operational execution of the company's gene-editing initiatives. Composed of experts in translational science, research and development, and technology, the team collaborates to advance innovative therapies from concept to clinical application, ensuring alignment with the company's goals and regulatory standards. Their collective experience fosters a culture of innovation and ensures efficient decision-making to propel the company's mission forward.

EdiTy Therapeutics

Org chart

Board & advisors

Teams

Research and Scientific Development

Leadership Team

Offices

EdiTy Therapeutics

Org chart

Board & advisors

Teams

Research and Scientific Development

Leadership Team

Offices

Related companies